Evidence map›Paper›PMID 28811344›Full record

ArticlemBio2017

The Capacity of

Krishna Kurthkoti, Hamel Amin, Mohlopheni J Marakalala, Saleena Ghanny, Selvakumar Subbian, Alexandra Sakatos, Jonathan Livny, Sarah M Fortune, Michael Berney, G Marcela Rodriguez

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 129 citations in OpenAlex.

  1. Review
  2. Review
  3. AnResearch square · 2026
    Article
  4. eLife · 2026
    Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Rv3839-Rv3840 links the endogenous heme biosynthesis pathway withbioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. International journal of nanomedicine · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Expression ofFrontiers in cellular and infection microbiology · 2025
    Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Krishna KurthkotiPublic Health Research Institute at New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
Hamel AminPublic Health Research Institute at New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
Mohlopheni J MarakalalaDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Saleena GhannyThe Genomics Center at New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
Selvakumar SubbianPublic Health Research Institute at New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.ORCID 0000-0003-2021-8632
Alexandra SakatosDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Jonathan LivnyThe Broad Institute, Cambridge, Massachusetts, USA.
Sarah M FortuneDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Michael BerneyDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
G Marcela RodriguezPublic Health Research Institute at New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA rodrigg2@njms.rutgers.edu.
Rutgers, The State University of New Jersey · USHarvard University · USAlbert Einstein College of Medicine · USBroad Institute · US

Funding

The roles of genes critical for growth under defined conditions in vitro or duriU19AI107774 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI CARR, STEVEN A, FORTUNE, SARAH · 2013 to 2017
$13.2M
The Graduate Program in Tropical Infectious Diseases (GPiTID)T32AI049928 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Flaminia Catteruccia, Phyllis J. Kanki · 2001 to 2026
$5.0M
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.R21AI119573 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERNEY, MICHAEL · 2016 to 2017
$459k
Defining the iron environment of M. tuberculosis granulomasR03AI122069 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI RODRIGUEZ, GLORIA MARCELA · 2016 to 2017
$159k
NIAID NIH HHS R03 AI122069NIAID NIH HHS R21 AI119573NIAID NIH HHS T32 AI049928NIAID NIH HHS U19 AI107774
6 · The paper itself

Abstract

This study was conducted to investigate the role of iron deprivation in the persistence of

Indexed as

Gene Expression ProfilingGranulomaHost-Pathogen InteractionsHumansIronLatent TuberculosisMetabolomicsMicrobial ViabilityMutationMycobacterium tuberculosisTuberculosisIroniron acquisitioniron deprivationiron sequestrationlatent TBMycobacterium tuberculosisnutritional immunitypersistenceTB granuloma

Identifiers

PMID28811344
PMCPMC5559634
OpenAlexW2749691721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.